Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Haleon publishes latest figures on share capital and voting rights
Haleon has announced that as of July 31, 2025, the company has a total of 8,987,651,560 issued ordinary shares, of which 3,880,205 are held as treasury shares. The total number of shares with voting rights therefore amounts to 8,983,771,355. This information serves as the basis for calculations in accordance with the transparency requirements of the Financial Conduct Authority. » Más en de.investing.com
Haleon appoints new members to committees
Haleon has appointed Bláthnaid Bergin to the audit and risk committee and Matt Shattock to the environmental and social sustainability committee. The appointments took immediate effect and were made in accordance with UK listing rules. The announcement was published by company secretary Amanda Mellor. » Más en de.investing.com
Haleon stock delivers 12.16 percent return over three years
An investment of £1,000 in Haleon three years ago would be worth £1,121.64 today, representing an increase of 12.16 percent. The calculation does not account for stock splits or dividends. Haleon was first listed on the stock exchange in July 2022 and currently has a market capitalization of £31.87 billion. » Más en finanzen.net
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | junio de 2025 | YoY |
|---|---|---|
| Ingresos | 3191,69 M | - |
| Beneficio bruto | 2058,87 M | - |
| Beneficio neto | 469,43 M | - |
| EBITDA | 811,32 M | - |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 40,23 mil M € |
Número de acciones | 8795,28 M |
Máximo/mínimo de 52 semanas | 5,16 € - 3,72 € |
Rentabilidad por dividendo | 1,88 % |
Dividendos TTM | 0,0842 € |
Beta | 0,24 |
Ratio P/E | 20,96 |
Ratio PEG | 3,56 |
Ratio P/B | 2,07 |
Ratio P/S | 3,00 |
Perfil de la empresa
Haleon plc se dedica a la investigación y desarrollo, la fabricación y la venta de diversos productos de salud de consumo en América del Norte, Europa, Oriente Medio, África, América Latina y Asia Pacífico. La empresa ofrece productos para la salud bucal terapéutica, el alivio del dolor, la salud respiratoria, la salud digestiva y otros productos, así como vitaminas, minerales y suplementos. Su cartera de marcas incluye Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax y Centrum. La empresa se conocía anteriormente como DRVW 2022 plc y cambió su nombre a Haleon plc en febrero de 2022. Haleon plc se constituyó en 2021 y tiene su sede en Brentford, Reino Unido.
| Nombre | Haleon PLC |
| CEO | Brian James McNamara |
| Sede | Weybridge,
su Reino Unido |
| Sitio web | |
| Sector | Consumo básico |
| Industria | Productos de cuidado personal |
| Salida a bolsa | 18/07/2022 |
| Empleados | 24.561 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
Pnk | HLNCF |
London Stock Exchange | HLN.L |
XETRA | H6D0.DE |
Frankfurt | H6D0.F |
Düsseldorf | H6D0.DU |
Hamburg | H6D0.HM |
London | HLN.L |
München | H6D0.MU |
